GET THE APP

Virology & Mycology

Virology & Mycology
Open Access

ISSN: 2161-0517

+44 1223 790975

Abstract

Determinants of Opportunistic Disease among Patients Attending ART Clinic, in Western Oromia, Ethiopia

Meseret Belete Fite*, Demeke Jabessa Aga and Habtamu Fekadu Gemede

Introduction: Human Immunodeficiency Virus (HIV), the causal agent for Acquired Immunodeficiency Syndrome (AIDS) is the world's greatest severe public health and development contest. Since the beginning of the epidemic, 38 million people are living with HIV/AIDS and 1.7 million people newly infected with HIV. Increased availability and accessibility of ART have essentially improved the survival rate, by lowering the incidence of OIs among people living with HIV/AIDS. The risk of developing Opportunistic infections in HIV patients depends on experience with potential pathogens, the virulence of pathogens, degree of host immunity, and the use of antimicrobial prophylaxis. In Ethiopia however remarkable decline of new infections (81%) for decades, since 2008 HIV incidence rate began to rise by 10% and the number of new infections diagnosed each year increased by 36% among all ages and doubled among adults. A limited study is describing the spectrum of opportunistic infection and associated factors in the study settings. Therefore, this study was aimed to determine the spectrum of opportunistic infections in the study area.

Methods: A facility-based retrospective cross-sectional study was employed from 2015-2019 G.C. The sample size was computed using the single population proportion formula. Accordingly, four hundred ninety-seven (497) medical records of study participants were reviewed. A simple random sampling technique was used to select the participants included in this study. Data were extracted from the ART follow-up database and medical records of the patients by using a standardized checklist, which was adopted from the Federal Ministry of Health HIV ART. The contents of the checklist include; socio-demographic characteristics and clinical information. Data had entered Epi data version 5.3.1 and analyzed using SPSS version 20. Bivariate analysis with a p-value <0.2 was done to see the association between outcome variables and independent variables. Variables with p<0.25 in bivariate analysis were entered for multiple logistic regressions. At 95% confidence interval, explanatory variables with P<0.05 in multiple logistic regression analysis were considered as a significant association.

Results: The study found that an overall prevalence of OIs was 62%. The finding of our study documented, from deferent HIV related OIs among patients on ART follow up at Nekemte Specialized Hospital ART clinic, the common types of OIs were; Pulmonary Tuberculosis (15.7%), Oral candidiasis (14.3%), Herpes Zoster (11.3%), Cryptococcus meningitides (5.9%), upper respiratory infection (5.8%, Persistent diarrhea (5.2%), and extra pulmonary tuberculosis (3.8%). The occurrence of OIs on adult PLHIV patients who were with baseline WHO stage of I was 53% lower as compared to those who were with advanced baseline WHO stage of II and more {AOR: 0.468, 95% CI (0.305-0.716). Moreover, Participants of Urban residents were 1.6 times more likely to develop OIs than those rural residents. Baseline WHO clinical staging and residence were identified as independent predictors of OIs among adult HIV-infected patients.

Conclusion: An overall prevalence of OIs was 62%. The prevalence of OIs is still high namely Pulmonary Tuberculosis, Oral candidiasis and Herpes Zoster are leading OIs among adult HIV-infected patients. Baseline WHO clinical staging and residence were identified as independent predictors of OIs among adult HIV infected patients.

Recommendations: Having skilled health professionals, early diagnosis of OIs among HIV infected patients, and having equipped laboratory diagnostic setup is mandatory to be able to deal with specific diagnoses and management of OIs. Further study is recommended to determine the relationship between residence and developing OIs among HIV patients on ART follow.

Published Date: 2022-03-22; Received Date: 2022-02-17

Top